articleJan 1, 2009Closed access

USE OF CHEMOTHERAPY PLUS A MONOCLONAL ANTIBODY AGAINST HER2 FOR METASTATIC BREAST CANCER THAT OVEREXPRESSES HER2

DED Ennis J. S LamonBRB Rian L EylandSHSarah HakHAH Ank F UchsVIV Irginia P Aton

Abstract

No abstract available for this paper.

Citation impact

1,201
total citations
FWCI
121.36
Percentile
100%
References
31
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Monoclonal antibody
  • Trastuzumab
  • Metastatic breast cancer
  • Breast cancer
  • Medicine
  • Chemotherapy
  • Oncology
  • Antibody
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.